Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV

Gastroenterology. 2002 Jan;122(1):244-5. doi: 10.1053/gast.2002.30901.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Drug Resistance, Viral
  • Fatal Outcome
  • HIV Infections / drug therapy*
  • Hepatitis B / drug therapy*
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / genetics*
  • Humans
  • Lamivudine / therapeutic use*
  • Liver Failure / virology*
  • Male
  • Middle Aged
  • Mutation

Substances

  • Anti-HIV Agents
  • Lamivudine